News

Find News

Filter articles

Showing 21 to 30 of 2541 results

Merck strengthens immunotherapy expertise with $773m buy

11-06-2019

US-based Merck & Co has announced plans to buy Tilos Therapeutics, its latest acquisition in the immunotherapy space.

USITC issues judgment in cholesterol testing strips dispute

US10-06-2019

The US International Trade Commission has issued a judgment after a surgical appliances company, Polymer Technology Systems (PTS), filed a complaint against a China-based competitor.

Eli Lilly petitions SCOTUS in $20m Cialis suit

US10-06-2019

Eli Lilly has asked the US Supreme Court to reconsider a lower court’s ruling which ordered the drugmaker to pay Germany-based Erfindergemeinschaft UroPep $20 million for patent infringement.

US patent reforms could re-establish gene patent eligibility, industry experts warn

US06-06-2019

A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.

EU General Court rejects lactic acid supplement TM

EU06-06-2019

The EU’s General Court has upheld the European Union Intellectual Property Office’s finding that a trademark for dietary supplements was descriptive of the relevant services to an Italian speaking public.

Eli Lilly licenses AI tech for preclinical development

US06-06-2019

San Francisco-based biotech company Atomwise could be set to receive up to $1 million per target in milestone payments following a partnership agreement with Eli Lilly.

German court deals blow to Sanofi over cholesterol drug

Germany05-06-2019

A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.

Danish biotech company secures CRISPR licence

Denmark, Ireland04-06-2019

Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.

Tokyo court dismisses Genentech patent suit against Sandoz

Japan04-06-2019

A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.

FDA warns stem cell company over unapproved treatments

US04-06-2019

The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.

Showing 21 to 30 of 2541 results

LSIPR